B-Cell Lymphome: Disease status
Item
patients with b-cell lymphoma, relapsing after high dose chemotherapy and autologous stem cell transplantation or allogeneneic stem cell or bone marrow transplant
boolean
C0079731 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C1328050 (UMLS CUI [3])
C1831743 (UMLS CUI [4])
C2242529 (UMLS CUI [5])
C0005961 (UMLS CUI [6])
Age
Item
age > 18 years old
boolean
C0001779 (UMLS CUI [1])
ANC and platelet count
Item
adequate hematologic function, as manifested by anc > 1000/mm3 and platelet count > 40,000/mm3
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
WHO Performance status
Item
ps who: < 3
boolean
C1298650 (UMLS CUI [1])
Organ function
Item
patients with serum creatinine > 2 mg%, transaminases (alt, ast) > 3 times upper normal value, direct bilirubin > 2 mg%, unless they result from tumor involvement
boolean
C0201976 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201916 (UMLS CUI [4])
Gynaecological status
Item
pregnant or lactating females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Myelodysplastic syndrome
Item
history of myelodysplastic syndrome
boolean
C3463824 (UMLS CUI [1])
CNS disease
Item
uncontrolled cns disease
boolean
C0007682 (UMLS CUI [1])
Infection
Item
active serious infection
boolean
C0009450 (UMLS CUI [1])
Vinorelbine and rituxan
Item
history of refractoriness to vinorelbine. however, prior treatment with rituxan is not an exclusion (synergy may still occur)
boolean
C0078257 (UMLS CUI [1])
C0732355 (UMLS CUI [2])